Landec Corporation Sets Second Quarter Fiscal Year 2018 Conference Call for January 4, 2018 at 8 a.m. PT and Earnings Release...
December 13 2017 - 9:15AM
Landec Corporation (Nasdaq:LNDC) will hold a conference call on
Thursday January 4, 2018 at 8 a.m. Pacific time to discuss its
results for the second quarter fiscal year 2018. Financial results
will be reported for the 2018 fiscal second quarter ended November
26, 2017 after market close on January 3, 2018.
Landec's President and CEO, Molly Hemmeter, will host the
Conference Call with Gregory S. Skinner, Vice President and CFO. A
question and answer period will follow the presentation.
Date: Thursday January 4, 2018Time: 8 a.m. Pacific time (11 a.m.
Eastern time)Toll Free Participant Dial-in Number: (844)
860-6243U.S. and International Toll Number: (661)
378-9884Conference ID: 7084189
Webcast: http://ir.Landec.com/events.cfmThe webcast will be
available for 30 days through February 3, 2018.
A replay of the teleconference will be available for one week
until midnight Eastern time Thursday January 11, 2018.
Toll free replay dial in: (855) 859-2056International replay:
(404) 537-3406Replay passcode: 7084189
About Landec Corporation
Landec Corporation (NASDAQ:LNDC) is a leading innovator of
diversified health and wellness solutions within the packaged
natural food and biomaterial markets. Apio, Landec's food business,
is the leader in branded, packaged fresh vegetables in North
America, utilizing its proprietary BreatheWay® packaging technology
to naturally extend the shelf life of fresh produce. Apio combines
this technology with the capabilities of a large national fresh
produce supplier to offer healthy fresh vegetable products under
the Eat Smart® brand to consumers through club and retail grocery
stores. Extending its reach into adjacent natural food products
outside of produce, Landec recently acquired O Olive Oil, Inc., an
organic and natural producer and marketer of olive oils and
vinegars under the O brand. Lifecore Biomedical, Landec’s
biomaterial business, is a fully integrated Contract Development
and Manufacturing Organization (CDMO) that offers expertise and
capabilities in fermentation, specialty formulation, aseptic
filling and final packaging for FDA regulated medical devices and
drugs to customers for applications in a wide array of markets
including Ophthalmic, Orthopedic and Oncology. For more information
about the company, visit Landec’s website at www.landec.com.
CONTACT: Media and Industry Contact:
At the Company:Gregory S. SkinnerVice President Finance and
CFO(650) 261-3677
Investor Relations:ICR, Inc.John Mills, Partner(646)
277-1254John.Mills@ICRINC.com
Landec (NASDAQ:LNDC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Landec (NASDAQ:LNDC)
Historical Stock Chart
From Apr 2023 to Apr 2024